Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
| Autor: | Coombes, RC, Kilburn, LS, Snowdon, CF, Paridaens, R, Coleman, RE, Jones, SE, Jassem, J, Van de Velde, CJH, Delozier, T, Alvarez, I, Del Mastro, L, Ortmann, O, Diedrich, K, Coates, AS, Bajetta, E, Holmberg, SB, Dodwell, D, Mickiewicz, E, Andersen, J, Lønning, PE, Cocconi, G, Forbes, J, Castiglione, M, Stuart, N, Stewart, A, Fallowfield, LJ, Bertelli, G, Hall, E, Bogle, RG, Carpentieri, M, Colajori, E, Subar, M, Ireland, E, Bliss, JM |
|---|---|
| Zdroj: | In The Lancet 2007 369(9561):559-570 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|